$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled drug delivery system for treatment of neural disorders 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-013/00
  • A61K-009/14
출원번호 US-0043695 (1987-04-29)
발명자 / 주소
  • Sabel Bernhard A. (Munich MA DEX) Freese Andrew (Jamaica Plain MA) Saltzman William M. (Somerville MA)
출원인 / 주소
  • Massachusetts Institute of Technology (Cambridge MA 02)
인용정보 피인용 횟수 : 237  인용 특허 : 11

초록

The present invention is a method and composition for treatment of ischemic, metabolic, congenital, or degenerative disorders of the central or peripheral nervous system. The composition is formed by encapsulation within an implantable biocompatible polymeric device of one or more compounds which ha

대표청구항

A method for treating disorders of the nervous system comprising: Selecting a compound which stimulates or replaces a specific function of components or the nervous system selected from the group consisting of L-dopa, dopamine, carbidopa, choline, acetyl choline, cholinergic neuronotropic agents, ga

이 특허에 인용된 특허 (11)

  1. Sidman Kenneth R. (Wayland MA), Biodegradable, implantable drug delivery device, and process for preparing and using the same.
  2. Bloch Rene (Savion IL) Kedem Ora (Rehovoth IL) Lobel Ester (Hulon IL), Controlled drug releasing preparations.
  3. Theeuwes Felix (Los Altos CA), Device with integrated operations for controlling release of agent.
  4. Higuchi ; Takeru ; Hussain ; Anwar, Drug-delivery device comprising certain polymeric materials for controlled release of drug.
  5. Sadek Safik E. (Wayland MA), Methods of improving control of release rates and products useful in same.
  6. Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL), Microencapsulation of water soluble active polypeptides.
  7. Zaffaroni Alejandro (Atherton CA), Novel drug delivery device.
  8. Michaels Alan S. (San Francisco CA) Guillod Mark S. (Kaneohe HI), Osmotic bursting drug delivery device.
  9. Appelgren Curt H. (V Frlunda SEX) Bogentoft Conny B. (Kallered SEX) Sjgren John A. (Mlnlycke SEX), Pharmaceutical preparation comprising a cardiac glycoside with a polymer coating.
  10. Theeuwes Felix (Los Altos CA), System with microporous reservoir having surface for diffusional delivery of agent.
  11. Folkman Moses J. (Brookline MA) Langer ; Jr. Robert S. (Allston MA), Systems for the controlled release of macromolecules.

이 특허를 인용한 특허 (237)

  1. Siegel, Steven; Winey, Karen, 9-OH-risperidone controlled release composition.
  2. Mavity William G. ; Stern Robert A. ; Osaki Shigemasa ; Zamora Paul O., Absorbable brachytherapy and chemotherapy delivery devices and methods.
  3. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Acoustically controlled reaction device.
  4. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Acoustically controlled reaction device.
  5. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Acoustically controlled reaction device.
  6. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Acoustically controlled substance delivery device.
  7. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Acoustically controlled substance delivery device.
  8. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Acoustically controlled substance delivery device.
  9. Bonutti, Peter M., Anchor for securing a suture.
  10. Chilcote, Tamie J.; Goldstein, Jason; Anderson, John P.; Walker, Donald, Antibodies to alpha synuclein.
  11. Chilcote, Tamie; Barbour, Robin, Antibodies to alpha-synuclein.
  12. LaDuca, Robert C.; LaDuca, Paul A., Apparatus and method for deploying an implantable device within the body.
  13. Bonutti, Peter M., Apparatus and method for securing a portion of a body.
  14. Bonutti, Peter M., Apparatus and method for tissue removal.
  15. Bonutti, Peter M., Apparatus and method for tissue removal.
  16. Sirhan, Motasim; Yan, John, Apparatus and methods for controlled substance delivery from implanted prostheses.
  17. Sirhan,Motasim; Yan,John, Apparatus and methods for variably controlled substance delivery from implanted prostheses.
  18. Zamora, Paul O.; Stern, Robert A., Bioabsorbable brachytherapy device.
  19. Athanasiou Kyriacos A. ; Boyan Barbara D., Biodegradable implant.
  20. Flaherty, J. Christopher; Van Wagenen, Richard A.; Smith, Christopher; Decaria, Christine; Branner, Almut; Harvey, Nephi, Biological interface system.
  21. Flaherty, J. Christopher, Biological interface system with automated configuration.
  22. Flaherty, J. Christopher, Biological interface system with gated control signal.
  23. Flaherty, J. Christopher; Caplan, Abraham H., Biological interface system with patient training apparatus.
  24. Flaherty, J. Christopher, Biological interface system with thresholded configuration.
  25. Blumenfeld, Andrew M., Botulinum toxin treatment of anxiety and bipolar disorders.
  26. Blumenfeld, Andrew M., Botulinum toxin treatments of depression.
  27. Blumenfeld, Andrew M.; Turkel, Catherine C.; Brin, Mitchell F., Botulinum toxin treatments of depression.
  28. Blumenfeld, Andrew M.; Turkel, Catherine C.; Brin, Mitchell F., Botulinum toxin treatments of depression.
  29. Blumenfeld, Andrew M., Botulinum toxin treatments of neurological and neuropsychiatric disorders.
  30. Frei,Mark G.; Osorio,Ivan; Rise,Mark T.; Giftakis,Jonathon E.; Graves,Nina M.; Carlson,David L.; Jensen,Randy M., Channel-selective blanking for a medical device system.
  31. Forman,Michael R., Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia.
  32. Forman,Michael R., Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia.
  33. Forman, Michael R., Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia.
  34. Rossomando, Anthony; Silvestre, Jean-Sebastien; Tamarat, Radia, Compositions and methods for increasing vascularization.
  35. Baetge Edward E. ; Hammang Joseph P. ; Gentile Frank T. ; Lindner Mark D. ; Winn Shelley R. ; Emerich Dwaine F., Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained i.
  36. Baetge Edward E. (Barrington RI) Hammang Joseph P. (Barrington RI) Gentile Frank T. (Warwick RI) Lindner Mark D. (Bristol RI) Winn Shelley R. (Smithfield RI) Emerich Dwaine F. (Providence RI), Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in.
  37. Baetge Edward E. ; Hammang Joseph P. ; Gentile Frank T. ; Lindner Mark D. ; Winn Shelley R. ; Emerich Dwaine F., Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules.
  38. Green, Allan M.; Gervais, Francine, Compounds and methods for modulating cerebral amyloid angiopathy.
  39. Athanasiou Kyriacos A ; Boyan Barbara D, Continuous release polymeric implant carrier.
  40. Dempski Robert E. (Dresher PA) Scholtz Edward C. (King of Prussia PA) Nibbelink Donald W. (Lansdale PA) Reines Scott A. (New Hope PA), Controlled release combination of carbidopa/levodopa.
  41. Forte, Michael; Bourdette, Dennis; Marracci, Gail, Cyclic undecapeptides and derivatives as multiple sclerosis therapies.
  42. Piens, Kathleen Camilla Telesphore Alida Maria; Vervecken, Wouter, De-mannosylation of phosphorylated N-glycans.
  43. Baetge Edward E. (Barrington RI) Hammang Joseph P. (Barrington RI) Gentile Frank T. (Warwick RI) Lindner Mark D. (Bristol RI) Winn Shelley R. (Smithfield RI) Emerich Dwaine F. (Providence RI), Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsules.
  44. Sirhan,Motasim; Yan,John, Delivery of therapeutic capable agents.
  45. Bellomo,Stephen F.; Lippin,Itzhak; Piva,Guillermo Alberto; Rosenberg,Lior; Bukhman,Mordechay; Stern,Baruch S.; Shalhevet,David; Shavitt,Menachem D.; Pearlman,Andrew L.; Shani,Noam; Almon,Einat, Dermal micro organs, methods and apparatuses for producing and using the same.
  46. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  47. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  48. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  49. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  50. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  51. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  52. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  53. Bellomo, Stephen F.; Lippin, Itzhak; Piva, Guillermo Alberto; Rosenberg, Lior; Bukhman, Mordechay; Stern, Baruch S.; Shalhevet, David; Shavitt, Menachem D.; Pearlman, Andrew L.; Shani, Noam; Almon, Einat, Dermal micro-organs, methods and apparatuses for producing and using the same.
  54. Bellomo, Stephen F.; Okun, Alex; Fuerst, Yaron; Shalhevet, David; Amir, Elisha; Bukhman, Mordechay, Dermal micro-organs, methods and apparatuses for producing and using the same.
  55. Bellomo, Stephen F.; Okun, Alex; Fuerst, Yaron; Shalhevet, David; Amir, Elisha; Bukhman, Mordechay, Dermal micro-organs, methods and apparatuses for producing and using the same.
  56. Bellomo, Stephen F.; Okun, Alex; Fuerst, Yaron; Shalhevet, David; Amir, Elisha; Bukhman, Mordechay, Dermal micro-organs, methods and apparatuses for producing and using the same.
  57. Kreuter Jorg,DEX ; Alyautdin Renad N.,RUX ; Karkevich Dimitri A.,RUX ; Sabel Bernhard A.,DEX, Drug targeting to the nervous system by nanoparticles.
  58. Siegel, Steven; Winey, Karen, Drug-containing PLA implants and methods of use thereof.
  59. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  60. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  61. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  62. Siegel, Steven; Winey, Karen, Drug-containing implants and methods of use thereof.
  63. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, Formulations and methods for providing prolonged local anesthesia.
  64. Charles B. Berde ; Robert S. Langer ; Joanne Curley ; Jenny Castillo, Formulations and methods for providing prolonged local anesthesia.
  65. Chasin Mark ; Sackler Richard ; Burch Ronald M. ; Goldenheim Paul ; Tigner Joseph, Formulations and methods for providing prolonged local anesthesia.
  66. Chasin, Mark; Goldenheim, Paul; Sackler, Richard; Tigner, Joseph; Burch, Ronald M, Formulations and methods for providing prolonged local anesthesia.
  67. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph, Formulations and methods for providing prolonged local anesthesia.
  68. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph, Formulations and methods for providing prolonged local anesthesia.
  69. Callewaert, Nico Luc Marc; Vervecken, Wouter; De Pourcq, Karen Jacqueline Marcel; Geysens, Steven Christian Jozef; Guerfal, Mouna, Glycosylation of molecules.
  70. Patel, Rajesh A.; Bhonsle, Sunil R., Heterogeneous implantable devices for drug delivery.
  71. Patel, Rajesh A.; Bhonsle, Sunil R., Heterogeneous implantable devices for drug delivery.
  72. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, High load formulations and methods for providing prolonged local anesthesia.
  73. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny, High load formulations and methods for providing prolonged local anesthesia.
  74. Yu, De Chao; Henderson, Daniel R.; Schuur, Eric R., Human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof.
  75. Basi, Guriq; Jacobsen, Jack Steven, Humanized Aβ antibodies for use in improving cognition.
  76. Basi, Guriq; Jacobsen, Jack Steven, Humanized antibodies that recognize beta amyloid peptide.
  77. Basi, Guriq; Saldanha, Jose, Humanized antibodies that recognize beta amyloid peptide.
  78. Basi, Guriq; Saldanha, Jose William, Humanized antibodies that recognize beta amyloid peptide.
  79. Basi, Guriq; Saldanha, Jose William; Schenk, Dale B., Humanized antibodies that recognize beta amyloid peptide.
  80. Basi,Guriq; Saldanha,Jose, Humanized antibodies that recognize beta amyloid peptide.
  81. Schenk, Dale B., Humanized antibodies that recognize beta amyloid peptide.
  82. Schenk, Dale B., Humanized antibodies that recognize beta amyloid peptide.
  83. Basi, Guriq; Saldanha, Jose William; Schenk, Dale B., Humanized antibodies that recognize β-amyloid peptide.
  84. Basi, Guriqbal; Schenk, Dale B.; Feinberg, Hadar Hana; Weis, William I., Hybrid amyloid-beta antibodies.
  85. Callewaert, Nico Luc Marc; Vervecken, Wouter; Tiels, Petra Sophie; Remaut, Han Karel; Piens, Kathleen Camilla Telesphore Alida Maria, Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose.
  86. Callewaert, Nico Luc Marc; Vervecken, Wouter; Tiels, Petra Sophie; Remaut, Han Karel; Piens, Kathleen Camilla Telesphore Alida Maria, Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose.
  87. Black, Ronald; Ekman, Lars; Lieberburg, Ivan; Grundman, Michael; Callaway, James; Gregg, Keith M.; Jacobsen, Jack Steven; Gill, Davinder; Tchistiakova, Lioudmila; Widom, Angela, Immunotherapy regimes dependent on ApoE status.
  88. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Scharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasconcellos Alfred V. ; Lysaght M, Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products.
  89. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Scharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasconcellos Alfred V. ; Lysaght M, Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products.
  90. Dionne, Keith E.; Emerich, Dwaine F.; Hoffman, Diane; Sanberg, Paul R.; Christenson, Lisa; Hegre, Orion D.; Scharp, David W.; Lacy, Paul E.; Aebischer, Patrick; Vasconcellos, Alfred V.; Lysaght, Mich, Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products.
  91. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Scharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasconcellos Alfred V. ; Lysaght M, Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products.
  92. Patel, Rajesh A.; Bucalo, Louis R.; Costantini, Lauren; Kleppner, Sofie, Implantable polymeric device for sustained release of dopamine agonist.
  93. Patel, Rajesh A.; Bucalo, Louis R.; Costantini, Lauren; Kleppner, Sofie, Implantable polymeric device for sustained release of dopamine agonist.
  94. Sebree, Terri B.; Siegel, Steven J., Implants for the treatment of dopamine associated states.
  95. Sebree, Terri B.; Siegel, Steven J., Implants for the treatment of dopamine associated states.
  96. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., In situ reaction device.
  97. Mitrani, Eduardo N., In vitro micro-organs, and uses related thereto.
  98. Wood, Jr., Lowell L.; Tegreene, Clarence T.; Gates, III, William H.; Hyde, Roderick A., Injectable controlled release fluid delivery system.
  99. Wood, Jr., Lowell L.; Tegreene, Clarence T.; Gates, III, William H.; Hyde, Roderick A., Injectable controlled release fluid delivery system.
  100. Donovan,Stephen; Francis,Joseph, Intracranial botulinum toxin therapy for focal epilepsy.
  101. Sirhan,Motasim; Yan,John, Intravascular delivery of methylprednisolone.
  102. Motasim Sirhan ; John Yan, Intravascular delivery of mycophenolic acid.
  103. Sirhan, Motasim; Yan, John, Intravascular delivery of mycophenolic acid.
  104. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  105. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  106. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  107. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  108. Pearlman, Andrew L.; Stern, Baruch S., Long lasting drug formulations.
  109. Pearlman, Andrew; Stern, Baruch S., Long lasting drug formulations.
  110. Bonutti, Peter M., Magnetic positioning apparatus.
  111. Piens, Kathleen Camilla Telesphore Alida Maria; Vervecken, Wouter; Valevska, Albena Vergilieva; Pynaert, Gwenda Noëlla, Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins.
  112. Piens, Kathleen Camilla Telesphore Alida Maria; Vervecken, Wouter; Valevska, Albena Vergilieva; Pynaert, Gwenda Noëlla, Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins.
  113. Babich,John W.; Zubieta,Jon; Bonavia,Grant, Matrices for drug delivery and methods for making and using the same.
  114. John W. Babich ; Jon Zubieta ; Grant Bonavia, Matrices for drug delivery and methods for making and using the same.
  115. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Method and system for control of osmotic pump device.
  116. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Method and system for control of osmotic pump device.
  117. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Method and system for control of osmotic pump device.
  118. Bonutti, Peter M., Method for forming and implanting a grafting material containing tissue.
  119. Bonutti, Peter M., Method for forming implant containing tissue.
  120. Bonutti,Peter M., Method for harvesting and processing cells from tissue fragments.
  121. Bonutti, Peter M., Method for tissue grafting.
  122. Bonutti,Peter M., Method for tissue grafting.
  123. Benowitz, Larry I., Method for treating stroke via administration of NEP1-40 and inosine.
  124. Bonutti,Peter M., Method for utilizing human tissue.
  125. Mesens Jean (Wechelderzande BEX) Rickey Michael E. (Loveland OH) Atkins Thomas J. (Cincinnati OH), Method of inhibiting neurotransmitter activity using microencapsulated 3-piperidiny2-substituted 1,2-benzisoxazoles and.
  126. Siegel, Steven; Winey, Karen, Method of maintaining therapeutic risperidone levels in a PLA:PLGA implant.
  127. Schenk, Dale B.; Bard, Frederique; Yednock, Theodore, Method of screening an antibody for activity in clearing an amyloid deposit.
  128. Bonutti, Peter M., Method of securing body tissue.
  129. Bonutti, Peter M., Method of securing tissue.
  130. Bonutti, Peter M.; Cremens, Matthew J.; Ruholl, Kevin, Method of using ultrasonic vibration to secure body tissue with fastening element.
  131. Benowitz,Larry I., Methods and compositions for modulating axonal outgrowth of central nervous system neurons.
  132. Ghatnekar, Gautam S.; Brower, Justin, Methods and compositions for the treatment of metabolic disorders.
  133. Kisilevsky Robert,CAX ; Green Allan M. ; Gervais Francine,CAX, Methods and compositions to treat glycosaminoglycan-associated molecular interactions.
  134. Vervecken, Wouter; Telesphore Alida Maria Piens, Kathleen Camilla; Ludo Stout, Jan Robert; Pynaert, Gwenda Noëlla, Methods and materials for treatment of pompe's disease.
  135. Raghavan, Raghu; Grossman, Stuart A., Methods and systems for providing planning and dispensation of research and/or treatment for brain disease.
  136. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Scharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasconcellos Alfred V. ; Lysaght M, Methods for coextruding immunoisolatory implantable vehicles with a biocompatible jacket and a biocompatible matrix core.
  137. Rossomando, Anthony; Silvestre, Jean-Sebastien; Tamarat, Radia, Methods for increasing vascularization.
  138. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Scharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasoohcellos Alfred V. ; Lysaght M, Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core.
  139. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Sharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasconcellos Alfred V. ; Lysaght Mi, Methods for making immunoisolatory implantable vehicles with a biocompatiable jacket and a biocompatible matrix core.
  140. Staas, Jay K.; Tice, Thomas R.; Hudson, Bruce W.; Tipton, Arthur J., Methods for manufacturing delivery devices and devices thereof.
  141. Benowitz, Larry I., Methods for modulating the axonal outgrowth of central nervous system neurons.
  142. Benowitz,Larry I., Methods for modulating the axonal outgrowth of central nervous system neurons.
  143. Larry I. Benowitz, Methods for modulating the axonal outgrowth of central nervous system neurons.
  144. Sackler, Richard S.; Goldenheim, Paul D.; Chasin, Mark; Burch, Ronald M.; Reder, Robert F.; Tigner, Joseph, Methods for providing safe local anesthesia.
  145. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Scharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasconcellos Alfred V. ; Lysaght M, Methods for treating diabetes by delivering insulin from biocompatible cell-containing devices.
  146. Dionne Keith E. ; Emerich Dwaine F. ; Hoffman Diane ; Sanberg Paul R. ; Christenson Lisa ; Hegre Orion D. ; Scharp David W. ; Lacy Paul E. ; Aebischer Patrick,CHX ; Vasconcellos Alfred V. ; Lysaght M, Methods for treatment or prevention of neurodegenerative conditions using immunoisolatory implantable vehicles with a bi.
  147. Baker Keith ; Kieras Mark ; Redmon Martin ; Pratt Daniel, Methods for universally distributing therapeutic agents to the brain.
  148. Sah, Dinah W. Y.; Johansen, Teit E.; Rossomando, Anthony, Methods of activating RET receptor tyrosine kinase using neurotrophic factors.
  149. Sah,Dinah W. Y.; Johansen,Teit E.; Rossomando,Anthony, Methods of treating pain using neurotrophic factors.
  150. Chilcote, Tamie; Barbour, Robin, Methods of using antibodies to detect alpha-synuclein in fluid samples.
  151. Tice, Thomas R.; Dillon, Deborah L.; Mason, David W.; McRae-McFarlane, Amanda; Dahlstrom, Annica B., Microcapsules for administration of neuroactive agents.
  152. Tice, Thomas R.; Mason, David W.; McRae-McFarlane, Amanda; Dahlstromm, Annica; Dillon, Deborah L.; Edens, Ramon, Microcapsules for administration of neuroactive agents.
  153. Mesens Jean,BEX ; Rickey Michael E. ; Atkins Thomas J., Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles.
  154. Atkins, Thomas J.; Rickey, Michael E.; Mesens, Jean, Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  155. Jean Mesens BE; Michael E. Rickey ; Thomas J. Atkins, Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  156. Mesens Jean,BEX ; Rickey Michael E. ; Atkins Thomas J., Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  157. Mesens Jean,BEX ; Rickey Michael E. ; Atkins Thomas J., Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  158. Mesens, Jean; Rickey, Michael E.; Atkins, Thomas J., Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  159. Mesens, Jean; Rickey, Michael E.; Atkins, Thomas J., Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  160. Mesens,Jean; Rickey,Michael E.; Atkins,Thomas J., Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles.
  161. Callewaert, Nico Luc Marc; Vervecken, Wouter; De Pourcq, Karen Jacqueline Marcel; Geysens, Steven Christian Jozef; Guerfal, Mouna, Microorganisms genetically engineered to have modified N-glycosylation activity.
  162. Callewaert, Nico Luc Marc; Vervecken, Wouter; De Pourcq, Karen Jacqueline Marcel; Geysens, Steven Christian Jozef; Guerfal, Mouna, Microorganisms genetically engineered to have modified N-glycosylation activity.
  163. Callewaert, Nico Luc Marc; Vervecken, Wouter; De Pourcq, Karen Jacqueline Marcel; Geysens, Steven Christian Jozef; Guerfal, Mouna, Microorganisms genetically engineered to have modified N-glycosylation activity.
  164. Donoghue,John Philip; Hatsopoulos,Nicholas George; Martel,Sylvain; Fofonoff,Timothy A.; Dyer,Robert J.; Hunter,Ian W., Microstructured arrays for cortex interaction and related methods of manufacture and use.
  165. Johansen, Teit E.; Blom, Nikolaj; Hansen, Claus, Neublastin neurotrophic factors.
  166. Rossomando, Anthony; Silvian, Laura; Pepinsky, R. Blake, Neublastin variants.
  167. Flaherty, J. Christopher; Capachione, L. Renée; Morris, Daniel S.; Caplan, Abraham H.; Saleh, Maryam; Guillory, K. Shane, Neural interface system with embedded id.
  168. Donoghue,John Philip; Hatsopoulos,Nicholas George; Serruya,Mijail Demian; Fellows,Matthew Richard; Paninski,Liam, Neurological signal decoding.
  169. Johansen, Teit E.; Blom, Nikolaj; Hansen, Claus, Neurotrophic factors.
  170. Sah,Dinah W. Y.; Johansen,Teit E.; Rossomando,Anthony, Neurotrophic factors.
  171. Sah, Dinah W. Y.; Johansen, Teit E.; Rossomando, Anthony, Neurotrophic factors and methods of use thereof.
  172. Nurmikko,Arto V.; Donoghue,John P.; Flaherty,J. Christopher; Patterson, III,William R., Optically-connected implants and related systems and methods of use.
  173. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Osmotic pump with remotely controlled osmotic flow rate.
  174. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Osmotic pump with remotely controlled osmotic pressure generation.
  175. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Osmotic pump with remotely controlled osmotic pressure generation.
  176. Flaherty, J. Christopher; Serruya, Mijail D.; Morris, Daniel S.; Caplan, Abraham H.; Saleh, Maryam; Donoghue, John P., Patient training routine for biological interface system.
  177. Wallach David,ILX ; Kost Josef,ILX ; Eliaz Rom,ILX, Pharmaceutical compositions for controlled release of soluble receptors.
  178. Boland, Edward J.; McDonough, Joe, Phenothiazine enantiomers as agents for the prevention of bone loss.
  179. Aebischer Patrick ; Tresco Patrick A., Planting devices for the focal release of neuroinhibitory compounds.
  180. Sah, Dinah Wen-Yee; Pepinsky, R. Blake; Rossomando, Anthony, Polymer conjugated glycosylated neublastin.
  181. Sah, Dinah Wen-Yee; Pepinsky, R. Blake; Boriack-Sjodin, Paula Ann; Miller, Stephan S.; Rossomando, Anthony; Silvian, Laura, Polymer conjugates of mutated neublastin.
  182. Sah,Dinah Wen Yee; Pepinsky,R. Blake; Boriack Sjodin,Paula Ann; Miller,Stephan S.; Rossomando,Anthony; Silvian,Laura, Polymer conjugates of mutated neublastin.
  183. Siegel, Steven J.; Winey, Karen I.; Gur, Raquel E.; Lenox, Robert H., Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use.
  184. Siegel, Steven J.; Winey, Karen I.; Gur, Raquel E.; Lenox, Robert H., Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use.
  185. Sah, Dinah Wen-Yee; Pepinsky, R. Blake; Rossomando, Anthony, Polymer-conjugated glycosylated neublastin.
  186. Sabel Bernhard A. (Egmating DEX) Freese Andrew (Jamaica Plain MA) Saltzman William M. (Baltimore MD) During Matthew J. (Westport CT), Polymeric device for controlled drug delivery to the CNS.
  187. Schenk, Dale B., Prevention and treatment of amyloidogenic disease.
  188. Schenk, Dale B., Prevention and treatment of amyloidogenic disease.
  189. Schenk, Dale B.; Vasquez, Nicki; Yednock, Theodore, Prevention and treatment of amyloidogenic disease.
  190. Schenk, Dale B.; Vasquez, Nicki; Yednock, Theodore, Prevention and treatment of amyloidogenic disease.
  191. Schenk, Dale B., Prevention and treatment of amyloidogenic diseases.
  192. Schenk, Dale B., Prevention and treatment of amyloidogenic diseases.
  193. Schenk, Dale B.; Masliah, Eliezar; Buttini, Manuel J.; Chilcote, Tamie J.; Rockenstein, Edward; Games, Kate Dora, Prevention and treatment of synucleinopathic and amyloidogenic disease.
  194. Schenk, Dale B.; Masliah, Eliezer, Prevention and treatment of synucleinopathic and amyloidogenic disease.
  195. Schenk, Dale B.; Masliah, Eliezer; Buttini, Manuel J.; Chilcote, Tamie J.; Rockenstein, Edward; Games, Kate Dora, Prevention and treatment of synucleinopathic and amyloidogenic disease.
  196. Schenk, Dale B.; Masliah, Eliezer; Buttini, Manuel; Chilcote, Tamie J.; Rockenstein, Edward M.; Games, Kate Dora, Prevention and treatment of synucleinopathic and amyloidogenic disease.
  197. Biggs, Danielle; Nettles, Heather, Process for preparing microparticles having a low residual solvent volume.
  198. Goldenheim Paul ; Lacouture Peter ; Donigi-Gale Donna ; Chasin Mark ; Sackler Richard, Prolonged anesthesia in joints and body spaces.
  199. Goldenheim, Paul; Donigi-Gale, Donna; Sackler, Richard; Lacouture, Peter; Chasin, Mark, Prolonged anesthesia in joints and body spaces.
  200. Sackler Richard ; Goldenheim Paul ; Chasin Mark, Prolonged local anesthesia with colchicine.
  201. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Reaction device controlled by magnetic control signal.
  202. Heruth, Kenneth T.; Lent, Mark S., Reduction of inflammatory mass with spinal catheters.
  203. Rossomando, Anthony; Pepinsky, R. Blake; Gong, BangJian, Refolding transforming growth factor beta family proteins.
  204. Rossomando, Anthony; Pepinsky, R. Blake; Gong, BangJian, Refolding transforming growth factor beta family proteins.
  205. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote control of osmotic pump device.
  206. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote control of substance delivery system.
  207. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote control of substance delivery system.
  208. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote controlled in situ reaction device.
  209. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote controlled in situ reaction device.
  210. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote controlled in situ reaction method.
  211. Goodall, Eleanor V.; Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote controlled in vivo reaction method.
  212. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote controlled in vivo reaction method.
  213. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote controller for in situ reaction device.
  214. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Remote controller for substance delivery system.
  215. Sagen Jaqueline, Reversing excitotoxic CNS damage by cellular implantation.
  216. Siegel, Steven; Winey, Karen, Risperidone-containing PLA:PGA implants and methods of use thereof.
  217. Siegel, Steven; Winey, Karen, Risperidone-containing implants and methods of use thereof.
  218. Iadonato, Shawn P.; Tarcha, Eric J., SHK-based pharmaceutical compositions and methods of manufacturing and using the same.
  219. Iadonato, Shawn P; Tarcha, Eric J, SHK-based pharmaceutical compositions and methods of manufacturing and using the same.
  220. Hoey Michael (Shoreview MN) Gehlbach Peter (Minneapolis MN), Smooth muscle chemical pacemaker.
  221. Hood, Leroy E.; Ishikawa, Muriel Y.; Jung, Edward K. Y.; Langer, Robert; Tegreene, Clarence T.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Substance delivery system.
  222. Bonutti,Peter M., Tissue cage.
  223. Bonutti,Peter M., Tissue graft material and method of making.
  224. Bonutti, Peter M., Tissue grafting material.
  225. Bonutti, Peter M., Tissue stabilizing implant method.
  226. Jackson Richard R. ; Williams John N., Tissue-numbing anesthetic articles.
  227. Creasey, Graham H.; Toong, Hoo-Min, Topical neurological stimulation.
  228. Flaherty, J. Christopher; Guillory, K. Shane; Serruya, Mijail D.; Caplan, Abraham H., Transcutaneous implant.
  229. Schenk, Dale B.; Masliah, Eliezer, Treatment and delay of outset of Parkinson's disease.
  230. Schenk, Dale B.; Masliah, Eliezar; Buttini, Manuel J.; Chilcote, Tamie J.; Rockenstein, Edward; Games, Kate Dora, Treatment and delay of outset of synucleinopathic and amyloidogenic disease.
  231. Schenk, Dale B., Treatment of amyloidogenic disease.
  232. Lieberburg, Ivan; Callaway, James; Grundman, Michael, Treatment of amyloidogenic diseases.
  233. Lieberburg, Ivan; Callaway, James; Grundman, Michael, Treatment of amyloidogenic diseases.
  234. Schroeter, Sally; Games, Kate Dora; Zago, Wagner, Treatment of cerebral amyloid angiopathy.
  235. Hauck, Wendy; Hamet, Pavel, Treatment of renal disorders, diabetic nephropathy and dyslipidemias.
  236. Merizzi, Gianfranco, Use of N-piperidine derivatives for the treatment of neurodegenerative pathologies.
  237. Arnault De La Menardiere, Brice Maxime; Alavar, Frederich Albert Lim; LaDuca, Robert C.; LaDuca, Paul A.; LaSalle, Carol, Vascular implants and methods of fabricating the same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로